UK markets closed

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2200-0.0300 (-1.33%)
At close: 01:00PM EST
2.2500 +0.03 (+1.35%)
After hours: 04:55PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 668.08M
Enterprise value 498.28M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)24.85
Price/book (mrq)2.37
Enterprise value/revenue 19.25
Enterprise value/EBITDA -4.39

Trading information

Stock price history

Beta (5Y monthly) 2.26
52-week change 3-43.51%
S&P500 52-week change 3-13.51%
52-week high 34.3500
52-week low 31.1600
50-day moving average 32.1864
200-day moving average 32.0482

Share statistics

Avg vol (3-month) 36.46M
Avg vol (10-day) 37.52M
Shares outstanding 5296.92M
Implied shares outstanding 6N/A
Float 8291.32M
% held by insiders 11.87%
% held by institutions 127.35%
Shares short (14 Nov 2022) 442.74M
Short ratio (14 Nov 2022) 44.93
Short % of float (14 Nov 2022) 414.40%
Short % of shares outstanding (14 Nov 2022) 414.39%
Shares short (prior month 13 Oct 2022) 446.73M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-468.22%

Management effectiveness

Return on assets (ttm)-22.17%
Return on equity (ttm)-37.50%

Income statement

Revenue (ttm)25.89M
Revenue per share (ttm)0.09
Quarterly revenue growth (yoy)55.10%
Gross profit (ttm)3.87M
EBITDA -112.33M
Net income avi to common (ttm)-116.87M
Diluted EPS (ttm)-0.3280
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)180.19M
Total cash per share (mrq)0.61
Total debt (mrq)10.39M
Total debt/equity (mrq)3.69
Current ratio (mrq)6.51
Book value per share (mrq)0.95

Cash flow statement

Operating cash flow (ttm)-115.92M
Levered free cash flow (ttm)-56.45M